Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-02

Clinical Trial Update: Leflunomide Versus Sulfasalazine/Methotrexate in Rheumatoid Arthritis:an Ultrasound/Magnetic Resonance Imaging Study [Phase 4]

View source ↗

Summary

Phase 4 trial comparing leflunomide with sulfasalazine/methotrexate in rheumatoid arthritis was terminated; ultrasound and MRI were used for assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARAVA (leflunomide)
  • Sulfasalazine/Methotrexate (Sulfasalazine; Methotrexate)

Snippet

Sponsor: Singapore General Hospital | Conditions: Rheumatoid Arthritis | Phase 4 | Status: TERMINATED